{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:32:31Z","timestamp":1790713951170,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.thromres.2017.10.025","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T04:31:41Z","timestamp":1509769901000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study"],"prefix":"10.1016","volume":"160","author":[{"given":"Y. Whitney","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2618-347X","authenticated-orcid":false,"given":"Stefano","family":"Barco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron A.A.","family":"Math\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik-Jan","family":"van den Dool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An K.","family":"Stroobants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille J.","family":"Serlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Coppens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2017.10.025_bb0005","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1177\/0148607114520994","article-title":"Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure","volume":"38","author":"Jeppesen","year":"2014","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.thromres.2017.10.025_bb0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s11605-009-1151-9","article-title":"The impact of intestinal failure on oral drug absorption: a review","volume":"14","author":"Ward","year":"2010","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.thromres.2017.10.025_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clnu.2015.01.011","article-title":"Prospective study of catheter-related central vein thrombosis in home parenteral nutrition patients with benign disease using serial venous Doppler ultrasound","volume":"35","author":"Cuerda","year":"2016","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.thromres.2017.10.025_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111216","article-title":"Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions","volume":"9","author":"Olthof","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2017.10.025_bb0025","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/jth.13351","article-title":"Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals","volume":"14","author":"Barco","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.10.025_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2013.12.017","article-title":"A comparative study of peripherally-inserted and Broviac catheter complications in home parenteral nutrition patients","volume":"34","author":"Toure","year":"2015","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.thromres.2017.10.025_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1054\/clnu.2000.0380","article-title":"Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre survey","volume":"20","author":"Van Gossum","year":"2001","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.thromres.2017.10.025_bb0040","first-page":"369","article-title":"Anticoagulants for the prevention and treatment of catheter-related thrombosis in adults and children on parenteral nutrition: a systematic review and critical appraisal","volume":"15","author":"Barco","year":"2017","journal-title":"Blood Transfus."},{"key":"10.1016\/j.thromres.2017.10.025_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.thromres.2017.10.025_bb0050","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.clnu.2016.08.003","article-title":"Primary thromboprophylaxis for adult patients on home parenteral nutrition: a comment on the 2016 ESPEN guideline","volume":"35","author":"Barco","year":"2016","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.thromres.2017.10.025_bb0055","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.clnu.2016.08.001","article-title":"Reply, letter to the editor - primary thromboprophylaxis for adult patients on home parenteral nutrition: a comment on the 2016 ESPEN guideline","volume":"35","author":"Cuerda","year":"2016","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.thromres.2017.10.025_bb0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0148607112460552","article-title":"Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000catheterdays","volume":"37","author":"Cotogni","year":"2013","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.thromres.2017.10.025_bb0065","first-page":"359","article-title":"Outcomes of a general hospital-based home parenteral nutrition (HPN) program; report of our experience from a 26-year period","volume":"30","author":"Higuera","year":"2014","journal-title":"Nutr. Hosp."},{"key":"10.1016\/j.thromres.2017.10.025_bb0070","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0140-6736(12)60409-7","article-title":"Heparin-induced skin lesions","volume":"380","author":"Schindewolf","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2017.10.025_bb0075","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMcp1411910","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2017.10.025_bb0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000073848","article-title":"Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism","volume":"33","author":"Wawrzynska","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.thromres.2017.10.025_bb0085","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0035-1544231","article-title":"Pros and cons of vitamin K antagonists and non-vitamin K antagonist oral anticoagulants","volume":"41","author":"Riva","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2017.10.025_bb0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.beha.2013.07.011","article-title":"New oral anticoagulants in elderly patients","volume":"26","author":"Barco","year":"2013","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.thromres.2017.10.025_bb0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/asheducation-2013.1.464","article-title":"Pros and cons of new oral anticoagulants","volume":"2013","author":"Bauer","year":"2013","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.thromres.2017.10.025_bb0100","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.110.004424","article-title":"Dabigatran etexilate: a new oral thrombin inhibitor","volume":"123","author":"Hankey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2017.10.025_bb0105","series-title":"Rivaroxaban. Product Monograph","author":"EMA","year":"2015"},{"key":"10.1016\/j.thromres.2017.10.025_bb0110","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/jth.12702","article-title":"Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS\/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants","volume":"12","author":"Schmitz","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.10.025_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.thromres.2017.10.025_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","article-title":"The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY trial (randomized evaluation of long-term anticoagulation therapy)","volume":"63","author":"Reilly","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2017.10.025_bb0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1160\/TH11-08-0551","article-title":"Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilate","volume":"107","author":"Hartter","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.10.025_bb0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0091270010393342","article-title":"Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, with coadministration of digoxin","volume":"52","author":"Stangier","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2017.10.025_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003088-200847010-00005","article-title":"Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects","volume":"47","author":"Stangier","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.thromres.2017.10.025_bb0140","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1538-7836.2004.00890.x","article-title":"Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I","volume":"2","author":"Eriksson","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.10.025_bb0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.thromres.2017.10.025_bb0150","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"Investigators","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2017.10.025_bb0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2017.10.025_bb0160","series-title":"Rivaroxaban. Highlights of Prescribing Information","author":"FDA","year":"2011"},{"key":"10.1016\/j.thromres.2017.10.025_bb0165","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1538-7836.2011.04498.x","article-title":"Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial","volume":"9","author":"Liesenfeld","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.10.025_bb0170","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/FJC.0b013e31822f6c2b","article-title":"Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban","volume":"58","author":"Moore","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.thromres.2017.10.025_bb0175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5414\/CP201812","article-title":"The effect of food on the absorption and pharmacokinetics of rivaroxaban","volume":"51","author":"Stampfuss","year":"2013","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2017.10.025_bb0180","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/0091270006286904","article-title":"Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects","volume":"46","author":"Kubitza","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2017.10.025_bb0185","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/0091270005274550","article-title":"Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement","volume":"45","author":"Stangier","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2017.10.025_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0261-5614(99)80002-8","article-title":"Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN-home artificial nutrition working group","volume":"18","author":"Bakker","year":"1999","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.thromres.2017.10.025_bb0195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/00365520500441247","article-title":"Home parenteral nutrition in Denmark in the period from 1996 to 2001","volume":"41","author":"Ugur","year":"2006","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2017.10.025_bb0200","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.thromres.2015.01.005","article-title":"Rivaroxaban as anticoagulant therapy in short bowel syndrome. Report of three cases","volume":"135","author":"Christensen","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.10.025_bb0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1160\/TH14-02-0104","article-title":"Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome","volume":"112","author":"Douros","year":"2014","journal-title":"Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817305418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817305418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T11:59:18Z","timestamp":1570276758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384817305418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":41,"alternative-id":["S0049384817305418"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.10.025","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}